Antiplatelet therapy for secondary prevention of the complications of atherothrombotic disease.
OBJECTIVE
To review and summarize key studies of secondary prevention of atherothrombotic events.


METHODS
English language clinical trials and guidelines.


METHODS
Key clinical trials and guidelines were selected by the authors based on their perceived importance and relevance to consultant pharmacists.


METHODS
The authors reviewed and summarized clinical trials and guidelines published in the English literature.


RESULTS
Each clinical trial and guideline was summarized by the authors.


CONCLUSIONS
Key clinical trials and guidelines regarding the secondary prevention of atherothrombotic events have great significance to consultant pharmacy.
wsimonsonpharmd@aol.com
William
W
Simonson
Judith L
JL
Beizer